BG103918A - Soluble sertraline compositions - Google Patents

Soluble sertraline compositions

Info

Publication number: BG103918A
Authority: BG; Bulgaria
Prior art keywords: compositions; soluble; soluble sertraline; sertraline compositions; sertraline
Prior art date: 1997-07-01

Application number

BG103918A

Other languages

Bulgarian (bg)

English (en)

Inventor

Dwayne T. Friesen

Scott M. Herbig

Ravi M. Shanker

James B. West

Original Assignee

Pfizer Products Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1999-11-23

Publication date

2000-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG103918(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-23 Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc

2000-07-31 Publication of BG103918A publication Critical patent/BG103918A/xx

Links

VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 title abstract 3
229960002073 sertraline Drugs 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
239000012736 aqueous medium Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BG103918A 1997-07-01 1999-11-23 Soluble sertraline compositions BG103918A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5141397P	1997-07-01	1997-07-01
PCT/IB1998/000933 WO1999001120A1 (fr)	1997-07-01	1998-06-15	Compositions de sertraline solubilisee

Publications (1)

Publication Number	Publication Date
BG103918A true BG103918A (en)	2000-07-31

Family

ID=21971159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG103918A BG103918A (en)	1997-07-01	1999-11-23	Soluble sertraline compositions

Country Status (34)

Country	Link
EP (1)	EP0999829A1 (fr)
JP (1)	JP2000514100A (fr)
KR (1)	KR100366373B1 (fr)
CN (1)	CN1261794A (fr)
AP (1)	AP1192A (fr)
AR (3)	AR015917A1 (fr)
AU (1)	AU742535B2 (fr)
BG (1)	BG103918A (fr)
BR (1)	BR9810739A (fr)
CA (1)	CA2290974C (fr)
CO (1)	CO4940495A1 (fr)
DZ (1)	DZ2548A1 (fr)
EA (1)	EA002481B1 (fr)
HN (1)	HN1998000102A (fr)
HR (1)	HRP980377A2 (fr)
HU (1)	HUP0002236A3 (fr)
ID (1)	ID23429A (fr)
IL (1)	IL133076A (fr)
IS (1)	IS5260A (fr)
MA (1)	MA24587A1 (fr)
NO (1)	NO996520L (fr)
OA (1)	OA11243A (fr)
PA (1)	PA8454301A1 (fr)
PE (1)	PE97199A1 (fr)
PL (1)	PL337804A1 (fr)
SK (1)	SK181099A3 (fr)
TN (1)	TNSN98124A1 (fr)
TR (1)	TR199903297T2 (fr)
TW (1)	TW550087B (fr)
UA (1)	UA67741C2 (fr)
UY (1)	UY25071A1 (fr)
WO (1)	WO1999001120A1 (fr)
YU (1)	YU68299A (fr)
ZA (1)	ZA985708B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GEP20053427B (en)	1999-12-23	2005-01-25	Pfizer Prod Inc	Pharmaceutical Compositions Providing Enhanced Drug Concentrations
US20030086972A1 (en) *	2000-08-09	2003-05-08	Appel Leah E.	Hydrogel-driven drug dosage form
AP2001002264A0 (en)	2000-08-30	2001-09-30	Pfizer Prod Inc	Sustained release formulations for growth hormone secretagogues.
US20040191207A1 (en) *	2003-03-31	2004-09-30	Lipari John M.	Alpha-hydroxy acid ester drug delivery compositions and methods of use
ES2439582T3 (es) *	2007-03-12	2014-01-23	Dsm Ip Assets B.V.	Composiciones cosméticas
DK2468281T3 (en)	2009-08-19	2016-03-21	Eisai R&D Man Co Ltd	Quinolinderivatholdig pharmaceutical composition
JPWO2011081117A1 (ja) *	2009-12-29	2013-05-09	興和株式会社	経口投与用固形医薬組成物
KR20120116422A (ko) *	2009-12-29	2012-10-22	코와 가부시키가이샤	경구 투여용 의약 조성물
CN109908354A (zh) *	2017-12-12	2019-06-21	万特制药(海南)有限公司	盐酸舍曲林口服浓缩液及其制备工艺
CN114894736B (zh) *	2022-05-20	2025-03-21	中化地质矿山总局地质研究院	一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
ATE96999T1 (de) *	1989-08-30	1993-11-15	Pfizer	Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
ZA97976B (en) *	1996-04-05	1997-08-18	Alza Corp	Uniform drug delivery theraphy.

1998
- 1998-06-15 EP EP98923019A patent/EP0999829A1/fr not_active Withdrawn
- 1998-06-15 BR BR9810739-9A patent/BR9810739A/pt not_active Application Discontinuation
- 1998-06-15 ID IDW991701A patent/ID23429A/id unknown
- 1998-06-15 SK SK1810-99A patent/SK181099A3/sk unknown
- 1998-06-15 PL PL98337804A patent/PL337804A1/xx unknown
- 1998-06-15 CA CA002290974A patent/CA2290974C/fr not_active Expired - Fee Related
- 1998-06-15 TR TR1999/03297T patent/TR199903297T2/xx unknown
- 1998-06-15 KR KR10-1999-7011361A patent/KR100366373B1/ko not_active Expired - Fee Related
- 1998-06-15 IL IL13307698A patent/IL133076A/xx not_active IP Right Cessation
- 1998-06-15 HU HU0002236A patent/HUP0002236A3/hu unknown
- 1998-06-15 AU AU75448/98A patent/AU742535B2/en not_active Ceased
- 1998-06-15 YU YU68299A patent/YU68299A/sh unknown
- 1998-06-15 JP JP11506774A patent/JP2000514100A/ja active Pending
- 1998-06-15 WO PCT/IB1998/000933 patent/WO1999001120A1/fr not_active Ceased
- 1998-06-15 EA EA199900962A patent/EA002481B1/ru unknown
- 1998-06-15 UA UA99116391A patent/UA67741C2/uk unknown
- 1998-06-15 CN CN98806763A patent/CN1261794A/zh active Pending
- 1998-06-25 AP APAP/P/1998/001280A patent/AP1192A/en active
- 1998-06-25 TW TW087110267A patent/TW550087B/zh active
- 1998-06-26 PE PE1998000573A patent/PE97199A1/es not_active Application Discontinuation
- 1998-06-29 AR ARP980103146A patent/AR015917A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25071A patent/UY25071A1/es not_active IP Right Cessation
- 1998-06-29 PA PA19988454301A patent/PA8454301A1/es unknown
- 1998-06-30 ZA ZA9805708A patent/ZA985708B/xx unknown
- 1998-06-30 MA MA25146A patent/MA24587A1/fr unknown
- 1998-06-30 DZ DZ980158A patent/DZ2548A1/fr active
- 1998-06-30 TN TNTNSN98124A patent/TNSN98124A1/fr unknown
- 1998-07-01 CO CO98037137A patent/CO4940495A1/es unknown
- 1998-07-01 HR HR60/051,413A patent/HRP980377A2/hr not_active Application Discontinuation
- 1998-07-01 HN HN1998000102A patent/HN1998000102A/es unknown
1999
- 1999-11-19 IS IS5260A patent/IS5260A/is unknown
- 1999-11-23 BG BG103918A patent/BG103918A/xx unknown
- 1999-12-21 OA OA9900301A patent/OA11243A/en unknown
- 1999-12-28 NO NO996520A patent/NO996520L/no not_active Application Discontinuation
2003
- 2003-06-19 AR ARP030102179A patent/AR040279A2/es unknown
- 2003-06-19 AR ARP030102180A patent/AR040280A2/es unknown

Also Published As

Publication number	Publication date
PA8454301A1 (es)	2000-09-29
IL133076A0 (en)	2001-03-19
ZA985708B (en)	2000-01-10
AU7544898A (en)	1999-01-25
SK181099A3 (en)	2000-07-11
DZ2548A1 (fr)	2003-02-08
PE97199A1 (es)	1999-10-05
WO1999001120A1 (fr)	1999-01-14
AR040279A2 (es)	2005-03-23
AP9801280A0 (en)	1998-06-30
KR20010013365A (fr)	2001-02-26
AU742535B2 (en)	2002-01-03
YU68299A (sh)	2002-06-19
CA2290974C (fr)	2004-04-27
NO996520L (no)	2000-02-29
HUP0002236A3 (en)	2003-12-29
KR100366373B1 (ko)	2003-01-14
UY25071A1 (es)	2000-12-29
IL133076A (en)	2003-12-10
OA11243A (en)	2003-07-24
CA2290974A1 (fr)	1999-01-14
TR199903297T2 (xx)	2000-07-21
IS5260A (is)	1999-11-19
BR9810739A (pt)	2000-09-12
MA24587A1 (fr)	1998-12-31
TW550087B (en)	2003-09-01
HRP980377A2 (en)	1999-04-30
CO4940495A1 (es)	2000-07-24
AR015917A1 (es)	2001-05-30
UA67741C2 (uk)	2004-07-15
HUP0002236A2 (hu)	2003-08-28
CN1261794A (zh)	2000-08-02
AR040280A2 (es)	2005-03-23
EP0999829A1 (fr)	2000-05-17
NO996520D0 (no)	1999-12-28
HN1998000102A (es)	1999-01-08
PL337804A1 (en)	2000-09-11
ID23429A (id)	2000-04-20
TNSN98124A1 (fr)	2005-03-15
EA002481B1 (ru)	2002-06-27
JP2000514100A (ja)	2000-10-24
EA199900962A1 (ru)	2000-08-28
AP1192A (en)	2003-07-23

Publication	Publication Date	Title
EP0680694A3 (fr)	1996-01-10	Compositions des biocides fluorescentes pour utilisation dans des systèmes aqueux.
ZA966404B (en)	1998-01-26	Ultramild aqueous cleansing compositions.
DE69716135D1 (en)	2002-11-07	In 6-position durch thio substituierte paclitaxele
HUP0103929A3 (en)	2002-08-28	Heterocyclyl amino methyloxazolidinones as antibacterials and pharmaceutical compositions containing the same
CA2260832A1 (fr)	1998-01-22	Utilisation d'une combinaison de tensioactifs, d'agents chelateurs et d'huiles essentielles pour une desinfection efficace
BG103930A (en)	2000-07-31	Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
GB9717905D0 (en)	1997-10-29	Lipid-containing compositions and uses thereof
NZ239879A (en)	1994-06-27	Cleansing composition comprising two amphoteric surfactants-one being an imidazolinium derivative, the other an aminoalkanoate or iminodialkanoate, and an insoluble conditioning agent
BG103918A (en)	2000-07-31	Soluble sertraline compositions
EP0608780A3 (fr)	1994-11-23	Compositions de fluorosilicones comme agents de démoulage.
EP1900802A3 (fr)	2008-06-11	Savon de toilette renfermant un acidifiant latent
HUP0102671A2 (hu)	2001-12-28	2',2'-difluor-nukleozid analógokat tartalmazó immunszupresszív hatású gyógyászati kompozíciók
ZA949151B (en)	1995-07-29	5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents.
AU1887399A (en)	1999-08-16	Aqueous compositions comprising complexing agents and uses therof
GB9406678D0 (en)	1994-05-25	Concentrated aqueous based surfactant compositions
ZA200105685B (en)	2002-01-31	Compositions comprising at least one UV screening agent and flavylinium salt which is unsubstituted in position 3, for colouring the skin, and uses thereof.
MY126868A (en)	2006-10-31	Suspension comprising oxcarbazepine
WO2002062304A3 (fr)	2003-02-27	Agents cosmetiques et/ou pharmaceutiques
AU2619099A (en)	1999-08-16	Aqueous precious metal colloids and the use thereof
WO2002056840A3 (fr)	2003-02-27	Produit cosmetique et/ou pharmaceutique
EP0665265A3 (fr)	1995-12-06	Compositions contenant des particules métalliques de taille nanométrique.
BG106534A (en)	2002-12-29	Oral solution containing galanthamine and a sweetening agent
AU1392000A (en)	2000-06-19	Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses
MX9708624A (es)	1998-02-28	Composiciones bacteriostaticas y su uso en fluidos de metalisteria.
CA2051892A1 (fr)	1993-01-02	Oxydes carboxyalkyliques et hydroxyalkyliques de polygalactomannanes, modifies par voie hydrophobe